Literature DB >> 7525972

A quaternary transcription termination complex. Reciprocal stabilization by Rho factor and NusG protein.

K W Nehrke1, T Platt.   

Abstract

The Escherichia coli protein NusG is known to modulate Rho-dependent transcription termination in vivo. We have shown that it can also alter the pattern of Rho-dependent RNA endpoints in vitro, at lower NusG concentrations than can be explained by reported interactions between NusG and Rho or RNA polymerase. Three observations in vitro now suggest a model to account for these effects of NusG on Rho-dependent termination. First, the presence of NusG circumvents the interference with Rho function caused by adding DNA oligonucleotides complementary to particular segments of the Rho binding site. Second, when NusG is added to stalled elongation complexes, the off-rate of Rho from nascent RNA is slowed. Third, NusG associates stably with the elongation complex only when Rho is also present and bound to the nascent RNA. Our observations are consistent with a model in which NusG and Rho participate in an interdependent association with the transcribing RNA polymerase and the nascent RNA to facilitate the recognition and use of termination signals. Common structural and functional features shared with complexes that carry out processive antitermination are discussed.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7525972     DOI: 10.1006/jmbi.1994.1685

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  22 in total

1.  Requirement for NusG for transcription antitermination in vivo by the lambda N protein.

Authors:  Ying Zhou; Joshua J Filter; Donald L Court; Max E Gottesman; David I Friedman
Journal:  J Bacteriol       Date:  2002-06       Impact factor: 3.490

2.  Crystal structures of transcription factor NusG in light of its nucleic acid- and protein-binding activities.

Authors:  Thomas Steiner; Jens T Kaiser; Snezan Marinkoviç; Robert Huber; Markus C Wahl
Journal:  EMBO J       Date:  2002-09-02       Impact factor: 11.598

3.  In vivo effect of NusB and NusG on rRNA transcription antitermination.

Authors:  Martha Torres; Joan-Miquel Balada; Malcolm Zellars; Craig Squires; Catherine L Squires
Journal:  J Bacteriol       Date:  2004-03       Impact factor: 3.490

4.  Structural basis for converting a general transcription factor into an operon-specific virulence regulator.

Authors:  Georgiy A Belogurov; Marina N Vassylyeva; Vladimir Svetlov; Sergiy Klyuyev; Nick V Grishin; Dmitry G Vassylyev; Irina Artsimovitch
Journal:  Mol Cell       Date:  2007-04-13       Impact factor: 17.970

5.  Functional specialization of transcription elongation factors.

Authors:  Georgiy A Belogurov; Rachel A Mooney; Vladimir Svetlov; Robert Landick; Irina Artsimovitch
Journal:  EMBO J       Date:  2008-12-18       Impact factor: 11.598

Review 6.  RNA polymerase elongation factors.

Authors:  Jeffrey W Roberts; Smita Shankar; Joshua J Filter
Journal:  Annu Rev Microbiol       Date:  2008       Impact factor: 15.500

7.  Vaccinia NPH-I, a DExH-box ATPase, is the energy coupling factor for mRNA transcription termination.

Authors:  L Deng; S Shuman
Journal:  Genes Dev       Date:  1998-02-15       Impact factor: 11.361

8.  E. coli NusG inhibits backtracking and accelerates pause-free transcription by promoting forward translocation of RNA polymerase.

Authors:  Kristina M Herbert; Jing Zhou; Rachel A Mooney; Arthur La Porta; Robert Landick; Steven M Block
Journal:  J Mol Biol       Date:  2010-04-08       Impact factor: 5.469

9.  Bicyclomycin sensitivity and resistance affect Rho factor-mediated transcription termination in the tna operon of Escherichia coli.

Authors:  C Yanofsky; V Horn
Journal:  J Bacteriol       Date:  1995-08       Impact factor: 3.490

10.  Cooperative stabilization of Mycobacterium tuberculosis rrnAP3 promoter open complexes by RbpA and CarD.

Authors:  Jayan Rammohan; Ana Ruiz Manzano; Ashley L Garner; Jerome Prusa; Christina L Stallings; Eric A Galburt
Journal:  Nucleic Acids Res       Date:  2016-06-24       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.